B9156

Butorphanol (+)-tartrate salt

≥99%

• Synonim(y): L-N-Cyclobutylmethyl-3,14-dihydroxymorphinan (+)-tartrate salt
• Wzór empiryczny (zapis Hilla): C₂₁H₂₉NO₂ · C₄H₆O₆
• Numer CAS: 58786-99-5
• Masa cząsteczkowa: 477.55
• NACRES: NA.77
• PubChem Substance ID: 24892126
• UNSPSC Code: 12352200
• EC Number: 261-443-5
• MDL number: MFCD00214257
• Assay: ≥99%
• Form: powder

Właściwości

• Quality Segment: 200
• assay: ≥99%
• form: powder
• drug control: USDEA Schedule IV; psychotrope (France); regulated under CDSA - not available from Sigma-Aldrich Canada
• originator: Bristol-Myers Squibb
• storage temp.: 2-8°C
• SMILES string: O[C@H]([C@@H](O)C(O)=O)C(O)=O.Oc1ccc2C[C@H]3N(CC[C@@]4(CCCC[C@@]34O)c2c1)CC5CCC5
• InChI: 1S/C21H29NO2.C4H6O6/c23-17-7-6-16-12-19-21(24)9-2-1-8-20(21,18(16)13-17)10-11-22(19)14-15-4-3-5-15;5-1(3(7)8)2(6)4(9)10/h6-7,13,15,19,23-24H,1-5,8-12,14H2;1-2,5-6H,(H,7,8)(H,9,10)/t19-,20+,21-;1-,2-/m11/s1
• InChI key: GMTYREVWZXJPLF-BTVKVFNOSA-N
• Gene Information: human ... OPRK1(4986), OPRM1(4988)

Opis

Biochem/physiol Actions

κ/μ opioid receptor agonist.

Features and Benefits

This compound was developed by Bristol-Myers Squibb. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Ta strona może zawierać tekst przetłumaczony maszynowo.

Informacja o środkach bezpieczeństwa

• pictograms: GHS08,GHS07
• signalword: Warning
• hcodes: H302,H361
• pcodes: P202 - P264 - P280 - P301 + P312 - P308 + P313 - P405
• Hazard Classifications: Acute Tox. 4 Oral - Repr. 2
• Klasa składowania: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable
• ppe: Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges